Company
Ascentage Pharma Group Inc.
Ascentage Pharma Group Inc. has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| APG-1252 | Phase 1 | EGFR Positive Non-small Cell Lung Cancer |
Latest
No recent events.
Follow Ascentage Pharma Group Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.